Skip to content
GLP-1 Scorecard
Menu
Site position #191

OrderlyMeds

Published by GLP-1 ScorecardUpdated

OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.

Visit OrderlyMedsWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)
Tirzepatide
$299/mo (compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh OrderlyMeds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value92/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment65/100
Contract terms55/100

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

What to consider

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • FDA issued OrderlyMeds LLC dba OrderlyMeds a warning letter in June 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want a first GLP-1 course at a published starter rate, with the standing rate published beside it.

Site position #191 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to OrderlyMeds LLC dba OrderlyMeds in June 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest OrderlyMeds — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect OrderlyMeds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on OrderlyMeds's site. Not medical advice; see our disclosure.

← Back to the scorecard